Back to results
US 12,594,267 B2Granted
Capsid inhibitors for the treatment of HIV
AssigneeGilead Sciences, Inc.
InventorsAnna Chiu, Charles William Rowe, Scott P. Sellers
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to compounds of Formula (Ia) and (Ib): or a pharmaceutically acceptable salt thereof, which are useful in the treatment of an HIV infection in heavily treatment-experienced patients with multidrug resistant HIV infection.
Claims13
A pharmaceutical composition consisting of a sodium salt of a compound of Formula (Ia):
- water, and PEG300, wherein the pharmaceutical composition is in the form of a solution consisting of about 20 w/w % to about 30 w/w % water, about 48 w/w % to about 60 w/w % PEG 300, and about 11 w/w % to about 28 w/w % of the sodium salt of the compound of Formula (Ia);
- and
- wherein the term “about” refers to +5 w/w %.
Dependencies are inferred from the claim text.